Male RTOG Normal Pelvis Atlas




Hiram A. Gay, M.D.,1 H. Joseph Barthold, M.D.,2 Elizabeth O'Meara, C.M.D.,3 Walter R. Bosch, Ph.D.,1 Issam El Naqa, Ph.D.,4 Rawan Al-Lozi,1 Seth A. Rosenthal, M.D.,5 Colleen Lawton, M.D., F.A.C.R.,6 W. Robert Lee, M.D.,7 Howard Sandler, M.D.,8 Anthony Zietman, M.D.,9 Robert Myerson, M.D., PH.D.,1 Laura A. Dawson, M.D.,10 Christopher Willett, M.D.,7 Lisa A. Kachnic, M.D.,11 Anuja Jhingran, M.D.,12 Lorraine Portelance, M.D.,13 Janice Ryu, M.D., 5 William Small, Jr., M.D., 14 David Gaffney, M.D., Ph.D., 15 Akila N. Viswanathan, M.D., M.P.H, 16 and Jeff M. Michalski, M.D.1

1 Washington University School of Medicine, St. Louis, MO; 2 Commonwealth Hematology & Oncology, Weymouth, MA, and Beth Israel Deaconess Medical Center, Boston, MA; 3 Radiation Therapy Oncology Group, Philadelphia, PA; 4 McGill University Health Center, Montreal, Quebec, Canada; 5 Radiation Oncology Centers, Radiological Associates of Sacramento, Sacramento, CA; 6Medical College of Wisconsin, Milwaukee, WI; 7 Duke University Medical Center, Durham, NC; 8 Cedars Sinai Medical Center, Los Angeles, CA; 9 Massachusetts General Hospital and Harvard Medical School, Boston, MA; 10 Princess Margaret Hospital, University of Toronto, Toronto, Canada; 11 Boston Medical Center, Boston University School of Medicine, Boston, MA; 12 M.D. Anderson Cancer Center, Houston, TX; 13 University of Miami, Miami, FL; 14 Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL; 15 Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; 16 Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, MA

Disclaimer: The materials presented on this web-site illustrate the consensus reached among cooperative groups and disease site committees. RTOG and authors are not responsible for any use of these guidances by third parties.